Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy
ChemistryOpen · 2025-12 · 14 (12)
DOI: 10.1002/open.202500305 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 10.08.2025. Verfasst von Abdüllatif Karakaya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, Zonguldak, 67600, Turkey. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Thiazoles, Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Themen: Demenz
Abstract (Originalsprache)
Herein, a series of novel 5‐hydroxymethylfuran incorporated thiazole‐based furan derivatives are synthesized and characterized. The in vitro inhibitory potentials of the derivatives against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are evaluated. In addition, the inhibitory potential of the thiazole‐based furan derivatives against AChE (4EY7) and BChE (4BDS) proteins is examined as in silico . For this purpose, the effects of the compounds on human metabolism are evaluated with absorption, distribution, metabolism, excretion, and toxicity programming. Furthermore, their antioxidant potential is assessed through 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) and 2,2′‐azino‐bis(3‐ethylbenzthiazoline‐6‐sulfonic acid) (ABTS) radical scavenging assays. The enzymatic inhibition studies reveal that all compounds exhibit inhibitory effects on both AChE and BChE. Among them, compound 2b demonstrates the most potent inhibition against AChE, with a K I value of 14.887 ± 1.054 μM, whereas compound 2f exhibits the highest inhibitory activity against BChE, with a K I value of 4.763 ± 0.321 μM. Compounds 2a (12.202% for DPPH and 56.842% for ABTS) and 2i (13.309% for DPPH and 31.842% for ABTS) are among the most active compounds for both radical scavenging tests. These findings highlight that the synthesized derivatives possess promising dual cholinesterase (ChE) inhibitory activity as well as radical scavenging potential. These activities emphasize their potential as therapeutic candidates for neurodegenerative disorders such as Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, Zonguldak, 67600, Turkey.
- Institute of Graduate Education, Anadolu University, Eskişehir, 26470, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, 26470, Turkey.
- Vocational School of Health Services, Pharmacy Services, Bilecik Şeyh Edebali University, Bilecik, 11230, Turkey.
- Vocational School of Health Services, Bilecik Şeyh Edebali University, Bilecik, 11230, Turkey.
- Department of Pharmacy Services, Vocational School of Health Services, Harran University, Şanlıurfa, 63300, Turkey.
ORCID-Profile: Ulviye Acar Çevik, Mesut Işık, Şükrü Beydemir, Yusuf Özkay, Zafer Asım Kaplancıklı
Förderung
- The Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Zitieren
APA
Karakaya, A., Acar Çevik, U., Kaya, B., Çiftçi, B., Necip, A., Işık, M., Beydemir, Ş., Özkay, Y., & Kaplancıklı, Z. A. (2025). Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy. ChemistryOpen, 14(12). https://doi.org/10.1002/open.202500305
Vancouver
Karakaya A, Acar Çevik U, Kaya B, Çiftçi B, Necip A, Işık M, et al. Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy. ChemistryOpen. 2025;14(12). doi:10.1002/open.202500305
BibTeX
@article{Karakaya2025,
author = {Karakaya, Abdüllatif and Acar Çevik, Ulviye and Kaya, Betül and Çiftçi, Bilge and Necip, Adem and Işık, Mesut and Beydemir, Şükrü and Özkay, Yusuf and Kaplancıklı, Zafer Asım},
title = {Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy},
journal = {ChemistryOpen},
year = {2025},
volume = {14},
number = {12},
doi = {10.1002/open.202500305}
}
EUVIMED